Cancer medicines, antibiotics become cheaper as NPPA slashes prices Industry-The Economic Times — October 8, 2016 comments off NPPA has also revised the prices of several cancer drugs in its latest list, including vincristine, bleomycin, cyclophosphamide and dacarbazine.
NPPA has also revised the prices of several cancer drugs in its latest list, including vincristine, bleomycin, cyclophosphamide and dacarbazine.